Early glycoprotein IIb–IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis

BACKGROUND: Even though time-to-treatment has been shown to be a determinant of mortality in primary angioplasty, the potential benefits from early pharmacological reperfusion by glycoprotein (Gp) IIb–IIIa inhibitors are still unclear. The aim of this meta-analysis was to combine individual data fro...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luca, G, Gibson, C M, Bellandi, F, Murphy, S, Maioli, M, Noc, M, Zeymer, U, Dudek, D, Arntz, H-R, Zorman, S, Gabriel, H M, Emre, A, Cutlip, D, Biondi-Zoccai, G, Rakowski, T, Gyongyosi, M, Marino, P, Huber, K, van’t Hof, A W J
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2008
Materias:
Acute Coronary Syndromes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582788/
https://www.ncbi.nlm.nih.gov/pubmed/18474534
http://dx.doi.org/10.1136/hrt.2008.141648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582788/
https://www.ncbi.nlm.nih.gov/pubmed/18474534
http://dx.doi.org/10.1136/hrt.2008.141648

Ejemplares similares